Contact me regarding this study
Babies must enroll by 14 days of age – contact us early to reserve your spot!
View More Studies
| Condition | Location | Status | Age Range | Sex | Max Compensation | |
|---|---|---|---|---|---|---|
| ACNE A Study comparing the Efficacy and Safety of Active Gel to Placebo in Treatment of Acne Vulgaris | Evansville | Recruiting | 9+ | $300 | Request Info | |
| ADHD Treatment of Impulsive Aggression in Subjects With ADHD in Conjunction With Standard ADHD Treatment (blind and open label extension) | Owensboro | Closed to Enrollment | 6 - 12 | $450/$850 | Request Info | |
| ALOPECIA AREATA Safety and efficacy, placebo-controlled with open-label extension study in patients with severe alopecia areata | Owensboro | Recruiting | 18 - 60 (Males) 18 - 70 (Females) | $950 | Request Info | |
| ANKYLOSING SPONDYLITIS (AS) Open label efficacy study comparing dosing strategies of a subcutaneous injectable biologic in patients with AS and accompanying back pain | Evansville | Recruiting | 18+ | $950 | Request Info | |
| ASTHMA Safety and Efficacy Study of a Fixed Dose Combination (FDC) in Subjects With Asthma | Evansville | Recruiting | 5 - 17 | $800 | Request Info | |
| ECZEMA (Atopic Dermatitis) Dose ranging, placebo-controlled study in patients with moderate to severe atopic dermatitis | Evansville | Recruiting | 18+ | $75 | Request Info | |
| ECZEMA (Atopic Dermatitis) Safety and efficacy, placebo-controlled with open-label extension study in patients with moderate to severe atopic dermatitis | Owensboro | Recruiting | 18+ | $550 - $1200 | Request Info | |
| HIDRADENITIS SUPPURATIVA (HS) Safety and efficacy, placebo-controlled study with re-randomization in patients with moderate to severe HS (Hurley Stage II and III) | Evansville | Recruiting | 18+ | $1075 | Request Info | |
| IBD - CROHN'S DISEASE A Safety and efficacy, placebo-controlled and active-controled comparison study for patients with moderate to severe Crohn's Disease | Owensboro Evansville | Recruiting | 18 - 80 | $3200 | Request Info | |
| IBD - ULCERATIVE COLITIS A Safety and efficacy, placebo-controlled and active-controled comparison study for patients with moderate to severe Ulcerative Colitis | Evansville | Recruiting | 18 - 80 | $1100 | Request Info | |
| INFANT FORMULA Comparison Study | Evansville | Recruiting | Newborns | Variable up to $150 plus supply of formula and diapers | Request Info | |
| INFANT VACCINE Comparison Study between two meningococcal vaccines | Evansville | Recruiting | Newborns | Variable up to $400 | Request Info | |
| LUPUS ERYTHEMATOSUS A Safety, efficacy and dose ranging comparison study for patients with moderate to severely active Systemic Lupus Erythematosus | Evansville | Recruiting | 18 - 65 | $750 | Request Info | |
| MOLLUSCUM CONTAGIONSUM An Open Label PK Study Assessing Safety, Tolerability, and PK of Topical Treatment of Molluscum Contagiosum | Owensboro Evansville | Closed to enrollment | 6 months - Adult | $1200 | Request Info | |
| PSORIASIS Dose Ranging, Safety and Efficacy, 16 week placebo-controlled with open-label follow-up study in patients with moderate to severe plaque psoriasis. | Owensboro | Closed to enrollment | 18-75 | $1050 | Request Info | |
| PSORIASIS A Vehicle Controlled Study, w/ Open Lable Extension to evaluate the Efficacy and Safety of 1% TOPICAL cream in treatment of mild to moderate plaque psoriasis | Owensboro Evansville | Recruiting | 18-75 | Up to $950 | Request Info | |
| RHEUMATOID ARTHRITIS (RA) Comparison Study between three biologics used to treat RA - Long Term Treatment | Evansville | Closed to Enrollment | 18+ | $375 during year 1 + $75 per simi-annual visit thereafter | Request Info | |